產(chǎn)品詳情
簡單介紹：
Anti-phospho-Cdc25B (Ser186)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-Cdc25B (Ser186)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-Cdc25B (Ser186)
Cat. Number:
Anti-phospho-Cdc25B (Ser186)抗體KL-5244R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
CDC25B is a member of the CDC25 family of phosphatases. CDC25B activates the cyclin dependent kinase CDC2 by removing two phosphate groups and it is required for entry into mitosis. CDC25B shuttles between the nucleus and the cytoplasm due to nuclear localization and nuclear export signals. The protein is Anti-phospho-Cdc25B (Ser186)抗體nuclear in the M and G1 phases of the cell cycle and moves to the cytoplasm during S and G2. CDC25B has oncogenic properties, although its role in tumor formation has not been determined. Multiple transcript variants for this gene exist. [provided by RefSeq, Jul 2008].
Also known as:
Cdc25B (Phospho-Ser186); Cdc25B (Phospho-S186); p-Cdc25B (Ser186); p-Cdc25B (S186); Cdc 25B; Cdc25b; Cdc-25b; CDC25HU2; Cdc25m2; Cell division cycle 25 homolog B; Cell division cycle 25B; Cell division cycle 25B isoform 1; Cell division cycle 25B isoform 2; Cell division cycle 25B isoform 3; Cell division cycleAnti-phospho-Cdc25B (Ser186)抗體 25B isoform 4; Cell division cycle 25B isoform 5; Dual specificity phosphatase Cdc25B; M phase inducer phosphatase 2; M-phase inducer phosphatase 2; MPIP2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Cdc25B around the phosphorylation site of Ser186.
●
Predicted Molecular Weight:Anti-phospho-Cdc25B (Ser186)抗體 65kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-phospho-Cdc25B (Ser186)抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-phospho-Cdc25B (Ser186)抗體dilutions must be determined by the end user.
kl859Bo01 凝集素樣氧化低密度脂蛋白受體1(LOX1)多克隆抗體 Polyclonal Antibody to Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)
kl859Hu01 凝集素樣氧化低密度脂蛋白受體1(LOX1)多克隆抗體 Polyclonal Antibody to Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)
kl859Mu01 凝集素樣氧化低密度脂蛋白受體1(LOX1)多克隆抗體 Polyclonal Antibody to Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)
kl859Ra01 凝集素樣氧化低密度脂蛋白受體1(LOX1)多克隆抗體 Polyclonal Antibody to Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)
kl859Rb51 凝集素樣氧化低密度脂蛋白受體1(LOX1)多克隆抗體 Polyclonal Antibody to Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)
kl860Hu01 胎球蛋白B(FETUB)多克隆抗體 Polyclonal Antibody to Fetuin B (FETUB)
kl860Ra01 胎球蛋白B(FETUB)多克隆抗體 Polyclonal Antibody to Fetuin B (FETUB)
kl866Hu01 神經(jīng)調(diào)節(jié)素1(NRG1)多克隆抗體 Polyclonal Antibody to Neuregulin 1 (NRG1)
kl866Mu01 神經(jīng)調(diào)節(jié)素1(NRG1)多克隆抗體 Polyclonal Antibody to Neuregulin 1 (NRG1)
kl866Ra01 神經(jīng)調(diào)節(jié)素1(NRG1)多克隆抗體 Polyclonal Antibody to Neuregulin 1 (NRG1)
kl867Hu01 表皮生長因子受體2(EGFR2)多克隆抗體 Polyclonal Antibody to Epidermal Growth Factor Receptor 2 (EGFR2)
kl867Mu01 表皮生長因子受體2(EGFR2)多克隆抗體 Polyclonal Antibody to Epidermal Growth Factor Receptor 2 (EGFR2)
kl867Ra01 表皮生長因子受體2(EGFR2)多克隆抗體 Polyclonal Antibody to Epidermal Growth Factor Receptor 2 (EGFR2)
kl871Hu01 G組著色性干皮病偶聯(lián)因子(XPG)多克隆抗體 Polyclonal Antibody to Xeroderma Pigmentosum, Complementation Group G (XPG)
kl872Hu01 CD3d分子(CD3d)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 3d (CD3d)
kl873Hu01 CD19分子(CD19)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 19 (CD19)
kl873Mu01 CD19分子(CD19)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 19 (CD19)
